Kala Pharmaceuticals Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Kala Pharmaceuticals (KALA) Tops Q2 EPS by 3c
August 6, 2019 7:58 AM EDTKala Pharmaceuticals (NASDAQ: KALA) reported Q2 EPS of ($0.70), $0.03 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $2.69 million.
For earnings history and earnings-related data on Kala Pharmaceuticals (KALA) click here.
... More